<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Levi-Drummer, R.S.</title>
    <link>http://repub.eur.nl/res/aut/5245/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis C patients: a case control study (Article)</title>
      <link>http://repub.eur.nl/res/pub/9824/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: High dose interferon induction treatment of hepatitis C viral
      infection blocks viral production over 95%. Since dose reduction is often
      performed due to clinical considerations, the effect of dose reduction on
      hepatitis C virus kinetics was studied. METHODS: A new model that allowed
      longitudinal changes in the parameters of viral dynamics was used in a
      group of genotype-1 patients (N = 15) with dose reduction from 10 to 3
      million units of interferon daily in combination with ribavirin, in
      comparison to a control group (N = 9) with no dose reduction. RESULTS:
      Dose reduction gave rise to a complex viral kinetic pattern, which could
      be only explained by a decrease in interferon effectiveness in blocking
      virion production. The benefit of the rapid initial viral decline
      following the high induction dose is lost after dose reduction. In
      addition, in some patients also the second phase viral decline slope,
      which is highly predictive of success of treatment, was impaired by the
      dose reduction resulting in smaller percentage of viral clearance in the
      dose reduction group. CONCLUSIONS: These findings, while explaining the
      failure of many induction schedules, suggest that for genotype-1 patients
      induction therapy should be continued till HCVRNA negativity in serum in
      order to increase the sustained response rate for chronic hepatitis C.</description>
    </item>
  </channel>
</rss>